Seol Ju Moon

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 11

Top Topics

Tandem Mass Spectrometry

Ultra High Performance Liquid Chromatography

Rheumatoid Arthritis Patients

Top Venues

Translational and clinical pharmacology

Expert opinion on biological therapy

Drug design, development and therapy

This page only lists publications with an associated author ORCID identifier.

Publications

Kyung-Sang Yu, Hyunwook Ryu, Dongseong Shin, Min-Kyu Park, Jun Gi Hwang, Seol Ju Moon, Min Gul Kim, Edward C Keystone, Josef S Smolen, SungHyun Kim, YunJu Bae, DaBee Jeon, JiYoung Jang, GoEun Yang, JiHun Bae, JaeYong Lee, Gerd R Burmester
Pharmacokinetics and safety of candidate tocilizumab biosimilar CT-P47 administered by auto-injector or pre-filled syringe: a randomized, open‑label, single-dose phase I study. Expert opinion on biological therapy 24 (7) (2024)
Kyung-Sang Yu, Hyunwook Ryu, Dongseong Shin, Min-Kyu Park, Jun Gi Hwang, Seol Ju Moon, Min Gul Kim, Edward C Keystone, Josef S Smolen, SungHyun Kim, YunJu Bae, DaBee Jeon, JiYoung Jang, GoEun Yang, JiHun Bae, JaeYong Lee, Gerd R Burmester
Pharmacokinetics and safety of candidate tocilizumab biosimilar CT-P47 administered by auto-injector or pre-filled syringe: a randomized, open‑label, single-dose phase I study. Expert opinion on biological therapy 24 (7) (2024)
Kyung-Sang Yu, Hyunwook Ryu, Dongseong Shin, Min-Kyu Park, Jun Gi Hwang, Seol Ju Moon, Min Gul Kim, Edward C Keystone, Josef S Smolen, SungHyun Kim, YunJu Bae, DaBee Jeon, JiYoung Jang, GoEun Yang, JiHun Bae, JaeYong Lee, Gerd R Burmester
Pharmacokinetics and safety of candidate tocilizumab biosimilar CT-P47 administered by auto-injector or pre-filled syringe: a randomized, open‑label, single-dose phase I study. Expert opinion on biological therapy 24 (7) (2024)
Kyung-Sang Yu, Hyunwook Ryu, Dongseong Shin, Min-Kyu Park, Jun Gi Hwang, Seol Ju Moon, Min Gul Kim, Edward C Keystone, Josef S Smolen, SungHyun Kim, YunJu Bae, DaBee Jeon, JiYoung Jang, GoEun Yang, JiHun Bae, JaeYong Lee, Gerd R Burmester
Pharmacokinetics and safety of candidate tocilizumab biosimilar CT-P47 administered by auto-injector or pre-filled syringe: a randomized, open‑label, single-dose phase I study. Expert opinion on biological therapy (2024)
In Sun Goak, Jin A Lee, Min Ho Jeong, Seol Ju Moon, Min Gul Kim
Pharmacokinetics of a Fixed-Dose Combination of Teneligliptin Hydrochloride Hydrate and Modified-Release Metformin Under Fasting and Fed Conditions in Healthy Subjects. Drug design, development and therapy 16 (2022)
Seol Ju Moon, Song-Hee Han, Yong-Geun Kwak, Min Gul Kim
Stability of acetylsalicylic acid in human blood collected using volumetric absorptive microsampling (VAMS) under various drying conditions. Translational and clinical pharmacology 30 (1) (2022)
In Sun Goak, Jin A Lee, Min Ho Jeong, Seol Ju Moon, Min Gul Kim
Pharmacokinetics of a Fixed-Dose Combination of Teneligliptin Hydrochloride Hydrate and Modified-Release Metformin Under Fasting and Fed Conditions in Healthy Subjects. Drug design, development and therapy 16 (2022)
In Sun Goak, Jin A Lee, Min Ho Jeong, Seol Ju Moon, Min Gul Kim
Pharmacokinetics of a Fixed-Dose Combination of Teneligliptin Hydrochloride Hydrate and Modified-Release Metformin Under Fasting and Fed Conditions in Healthy Subjects. Drug design, development and therapy 16 (2022)
Sangmi Lee, Eunwoo Kim, Seol Ju Moon, Jina Jung, Seung Hwan Lee, Kyung-Sang Yu
Comparative pharmacokinetics between tenofovir disoproxil phosphate and tenofovir disoproxil fumarate in healthy subjects. Translational and clinical pharmacology 29 (1) (2021)
Seol Ju Moon, Seon Eui Lee, Yong-Geun Kwak, Min Gul Kim
Validation of LC-MS/MS method for determination of rosuvastatin concentration in human blood collected by volumetric absorptive microsampling (VAMS). Translational and clinical pharmacology 29 (3) (2021)
Seol Ju Moon, Yunjeong Kim, Ji-Young Jeon, Shin-Jung Park, Yong-Geun Kwak, Min Gul Kim
Pharmacokinetic properties and bioequivalence of gefitinib 250 mg in healthy Korean male subjects. Translational and clinical pharmacology 29 (3) (2021)